Italia markets open in 4 hours 49 minutes

TEVA Jul 2024 14.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,18000,0000 (0,00%)
In data: 11:25AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,1800
Aperto2,1800
Denaro1,6700
Domanda2,5000
Prezzo d'esercizio14,50
Scadenza2024-07-26
Min-Max giorno2,1800 - 2,1800
Contratto - Min-MaxN/D
Volume1
Open Interest3
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.